This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Campbell, R. B. Articles by Munn, L. L. Search for Related Content PubMed PubMed Citation Articles by Campbell, R. B. Articles by Munn, L. L.

Cationic Charge Determines the Distribution of Liposomes between the Vascular and Extravascular Compartments of Tumors¹

Edwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts 02114 [R. B. C., D. F., E. B. B., Y. I., R. K. J., L. L. M.], and Department of Pharmaceutical Sciences, Boston, Massachusetts 02115 [L. M. M., V. P. T.]

Tumor vessels possess unique physiological features that might be exploited for improving drug delivery. In the present study, we investigate the possibility of modifying polyethylene glycol-ylated liposome cationic charge of polyethylene glycol coated liposomes to optimize delivery to tumor vessels using biodistribution studies and intravital microscopy. The majority of liposomes accumulated in the liver, and increasing charge resulted in lower retention in the spleen and blood. Although overall tumor uptake was not affected by charge in the biodistribution studies, intravital microscopy showed that increasing the charge content from 10 to 50 mol % doubled the accumulation of liposomes in tumor vessels, suggesting a change in intratumor distribution; no significant effect of charge on interstitial accumulation could be detected, possibly attributable to spatial heterogeneity. Increased vascular accumulation of cationic liposomes was similar in two different tumor types and sites. Our results suggest that optimizing physicochemical properties of liposomes that exploit physiological features of tumors and control the intratumor distribution of these drug carriers should improve vascular-specific delivery.

This article has been cited by other articles:

				Q. le Masne de Chermont, C. Chaneac, J. Seguin, F. Pelle, S. Maitrejean, J.-P. Jolivet, D. Gourier, M. Bessodes, and D. Scherman Nanoprobes with near-infrared persistent luminescence for in vivo imaging PNAS, May 29, 2007; 104(22): 9266 - 9271. [Abstract] [Full Text] [PDF]

				O. C. Farokhzad, J. Cheng, B. A. Teply, I. Sherifi, S. Jon, P. W. Kantoff, J. P. Richie, and R. Langer Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo PNAS, April 18, 2006; 103(16): 6315 - 6320. [Abstract] [Full Text] [PDF]

				T. Nakahara, S. M. Norberg, D. R. Shalinsky, D. D. Hu-Lowe, and D. M. McDonald Effect of Inhibition of Vascular Endothelial Growth Factor Signaling on Distribution of Extravasated Antibodies in Tumors Cancer Res., February 1, 2006; 66(3): 1434 - 1445. [Abstract] [Full Text] [PDF]

				S. E. McNeil Nanotechnology for the biologist J. Leukoc. Biol., September 1, 2005; 78(3): 585 - 594. [Abstract] [Full Text] [PDF]

				F. Pastorino, C. Brignole, D. Marimpietri, M. Cilli, C. Gambini, D. Ribatti, R. Longhi, T. M. Allen, A. Corti, and M. Ponzoni Vascular Damage and Anti-angiogenic Effects of Tumor Vessel-Targeted Liposomal Chemotherapy Cancer Res., November 1, 2003; 63(21): 7400 - 7409. [Abstract] [Full Text] [PDF]

				K. Braeckmans, L. Peeters, N. N. Sanders, S. C. De Smedt, and J. Demeester Three-Dimensional Fluorescence Recovery after Photobleaching with the Confocal Scanning Laser Microscope Biophys. J., October 1, 2003; 85(4): 2240 - 2252. [Abstract] [Full Text] [PDF]

				M. Schmitt-Sody, S. Strieth, S. Krasnici, B. Sauer, B. Schulze, M. Teifel, U. Michaelis, K. Naujoks, and M. Dellian Neovascular Targeting Therapy: Paclitaxel Encapsulated in Cationic Liposomes Improves Antitumoral Efficacy Clin. Cancer Res., June 1, 2003; 9(6): 2335 - 2341. [Abstract] [Full Text] [PDF]